BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 853542)

  • 1. A prospective on covalent binding and toxicity.
    Gillette JR; Pohl LR
    J Toxicol Environ Health; 1977 Mar; 2(4):849-71. PubMed ID: 853542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The state of the art: a commentary on the current practice of metabolism and pharmacokinetic studies in the pharmaceutical industry.
    Case DE
    Xenobiotica; 1981 Dec; 11(12):803-14. PubMed ID: 7342486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics in chronic animal toxicity studies.
    Yacobi A; Kamath BL; Lai CM
    Drug Metab Rev; 1982; 13(6):1021-51. PubMed ID: 6754316
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioavailability of residues: current status.
    Huber WG; Becker SR; Archer BP
    J Environ Pathol Toxicol; 1980; 3(5-6):45-63. PubMed ID: 7003045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and toxicity testing.
    Clark B; Smith DA
    Crit Rev Toxicol; 1984; 12(4):343-85. PubMed ID: 6378530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodology for the determination of bioavailability of labeled residues.
    Gallo-Torres HE
    J Toxicol Environ Health; 1977 Mar; 2(4):827-45. PubMed ID: 857043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of overloading pathways on toxicity.
    Wolf FJ
    J Environ Pathol Toxicol; 1980; 3(5-6):113-34. PubMed ID: 7441076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetic and metabolic studies in the development of drugs].
    Vereczkey L
    Acta Pharm Hung; 1995 Jul; 65(4):105-11. PubMed ID: 7572191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated pharmacokinetic-dynamic modeling of drugs acting on the CNS.
    Paalzow LK
    Drug Metab Rev; 1984; 15(1-2):383-400. PubMed ID: 6378561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism, disposition, and toxicity of drugs and other xenobiotics in aquatic species.
    Guarino AM; Lech JJ
    Vet Hum Toxicol; 1986; 28 Suppl 1():38-44. PubMed ID: 3334693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bioavailability of drugs--concepts and problems].
    Bekemeier H; Hirschelmann R
    Pharmazie; 1984 Jan; 39(1):59-62. PubMed ID: 6718470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bound residues of veterinary drugs: bioavailability and toxicological implications.
    Burgat-Sacaze V; Delatour P; Rico A
    Ann Rech Vet; 1981; 12(3):277-89. PubMed ID: 7344560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of non-linear (dose-dependent) pharmacokinetics in hazard assessment.
    Watanabe PG; Young JD; Gehring PJ
    J Environ Pathol Toxicol; 1977; 1(2):147-59. PubMed ID: 553128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for estimating drug bioavailability parameters. Part 3: Peculiarities of pharmacokinetic analysis in assessment of bioavailability.
    Firsov AA; Piotrovskii VK
    Pharmazie; 1986 Jul; 41(7):457-65. PubMed ID: 3534896
    [No Abstract]   [Full Text] [Related]  

  • 17. Toxicological significance of covalently-bound residues.
    Rico AG; Burgat-Sacaze V
    Food Addit Contam; 1984; 1(2):157-61. PubMed ID: 6536527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic considerations in toxicity testing.
    Jollow DJ; Roberts S; Price V; Longacre S; Smith C
    Drug Metab Rev; 1982; 13(6):983-1007. PubMed ID: 6754320
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioavailability and safety of nonextractable bound drug-related residues.
    Sieck RF
    J Toxicol Environ Health; 1977 Mar; 2(4):847. PubMed ID: 853541
    [No Abstract]   [Full Text] [Related]  

  • 20. [Capacity limited pharmacokinetics, a mechanism of drug toxicity (author's transl)].
    Dettli L
    Arzneimittelforschung; 1977; 27(96):1844-8. PubMed ID: 579151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.